These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area. Chang KS, Wang LC, Gao CL, Alexander S, Ting RC, Bodner A, Log T, Kuo AF, Strickland P. Eur J Epidemiol; 1988 Dec; 4(4):426-34. PubMed ID: 2904886 [Abstract] [Full Text] [Related]
26. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Schüpbach J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC. Science; 1984 May 04; 224(4648):503-5. PubMed ID: 6200937 [Abstract] [Full Text] [Related]
28. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Safai B, Sarngadharan MG, Groopman JE, Arnett K, Popovic M, Sliski A, Schüpbach J, Gallo RC. Lancet; 1984 Jun 30; 1(8392):1438-40. PubMed ID: 6145881 [Abstract] [Full Text] [Related]
29. Diversity of clinical spectrum of HTLV-III infection. Valle SL, Saxinger C, Ranki A, Antonen J, Suni J, Lähdevirta J, Krohn K. Lancet; 1985 Feb 09; 1(8424):301-4. PubMed ID: 2857362 [Abstract] [Full Text] [Related]
30. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Science; 1984 May 04; 224(4648):506-8. PubMed ID: 6324345 [Abstract] [Full Text] [Related]
31. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III). Sirianni MC, Rossi P, Scarpati B, Ragona G, Seminara R, Bonomo G, Aiuti F. J Clin Immunol; 1985 Jul 04; 5(4):261-8. PubMed ID: 2995433 [Abstract] [Full Text] [Related]
32. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs. Goudsmit J, Miedema F, Breederveld C, Terpstra F, Roos M, Schellekens P, Melief C. Vox Sang; 1986 Jul 04; 50(1):12-5. PubMed ID: 3006351 [Abstract] [Full Text] [Related]
35. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P, Weaver M, Wiggs B, O'Shaughnessy M. Can Med Assoc J; 1985 Aug 15; 133(4):286-92. PubMed ID: 2990652 [Abstract] [Full Text] [Related]
36. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III. Abb J. Med Microbiol Immunol; 1985 Aug 15; 174(4):205-10. PubMed ID: 2999573 [Abstract] [Full Text] [Related]
37. Immunopathogenesis of the acquired immunodeficiency syndrome. Bowen DL, Lane HC, Fauci AS. Ann Intern Med; 1985 Nov 15; 103(5):704-9. PubMed ID: 2996403 [Abstract] [Full Text] [Related]
38. Human T-cell leukemia virus specific antigens. Lee TH, Coligan JE, Essex M. Princess Takamatsu Symp; 1984 Nov 15; 15():197-203. PubMed ID: 6100639 [Abstract] [Full Text] [Related]
39. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C, Levine PH, Dean A, Lange-Wantzin G, Gallo R. Cancer Res; 1985 Sep 15; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [Abstract] [Full Text] [Related]